Pergolide protects dopaminergic neurons in primary culture under stress conditions

Journal of Neural Transmission

Volumn 109, Issue 5-6, 2002, Pages 633-643

  Gille, G ^a   Rausch, W D ^b   Hung, S T ^b   Moldzio, R ^b   Janetzky, B ^a   Hundemer, H P ^c   Kolter, T ^c   Reichmann, H ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

Dopamine uptake; L DOPA; MPP+; Neuroprotection; Parkinson's disease; Pergolide

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; DOPAMINE 2 RECEPTOR STIMULATING AGENT; LACTIC ACID; LEVODOPA; PERGOLIDE;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; DRUG EFFICACY; DRUG MECHANISM; EMBRYO; FEMALE; MESENCEPHALON; MOUSE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STRESS;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; DOPAMINE AGENTS; DOPAMINE AGONISTS; LEVODOPA; MESENCEPHALON; MICE; MICE, INBRED C57BL; NEURONS; NEUROPROTECTIVE AGENTS; PERGOLIDE; STRESS; TYROSINE 3-MONOOXYGENASE;

EID: 0036327342     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020200052     Document Type: Article

References (33)

1. + neurotoxicity against rat dopaminergic neurons in culture
2. Protective effects of pergolide on dopamine levels in the 6-hydroxydopamine-lesioned mouse brain
3. Der l-dioxyphenylalanineffekt bei der Parkinson-Akinese
4. +, oxidant and specific neurotoxicants share the common molecular mechanism
5. The effect of pergolide and MDL 72794 on rat brain CuZn superoxide dismutase
6. Effects of pergolide on endogenous and exogenous L-dopa metabolism in rat striatum: A microdialysis analysis
7. Dopamine agonists
8. Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 rats
9. Protection of dopaminergic neurons in primary culture by lisuride
10. Pergolide scavenges both hydroxyl and nitric free radicals in vitro and inhibits lipid peroxidation in different regions of the rat brain
11. Low dosages of bromocriptine added to levodopa in Parkinson's disease
12. The rationale for the use of dopamine agonists in Parkinson's disease
13. Oxidative stress and the pathogenesis of Parkinson's disease
14. + in co-cultures from mesencephalon and striatum of embryonic C57BL/6 mice
15. Clinical pharmacology of dopamine agonists
16. Clinical pharmacology of dopamine agonists in Parkinson's disease
17. Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease
18. Glia protect fetal midbrain dopaminergic neurons in culture from L-DOPA toxicity through multiple mechanisms
19. Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture
20. +) is toxic to mesencephalic dopamine neurons in culture
21. Toxic and protective effects of L-DOPA on mesencephalic cell cultures
22. Catecholamine-related enzymes in the brain of patients with Parkinsonism and Wilson's disease
23. The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: The role of mitochondrial complex I and reactive oxygen species revisited
24. A rationale for dopamine agonists as primary therapy for Parkinson's disease
25. A multi-center, double-blind, placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease
26. Dopamine agonists and neuroprotection in Parkinson's disease
27. L-dopa inhibits complex IV of the electron transport chain in catecholamine-rich human neuroblastoma NB69 cells
28. 3 receptor-preferring agonist: Comparison to other dopamine receptor agonists
29. Mechanisms of MPTP toxicity
30. Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity
31. Antipar kinsonian therapies and brain mitochondrial complex I activity
32. Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial
33. 2